Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.
1
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
2
Where do you stand?
Choose your position
3
Tell your reps
Take a position to see your representatives and ways to contact them.
4
More on this bill
Where it stands
Introduced
2Passed Senate
3Passed House
4To Governor
5Became Law
Looking ahead
No hearings or votes scheduled.
History
2026
May 26Comp. became Pub. Ch. 1016Latest
Apr 17Sponsor(s) Added.Minor
Apr 16Companion House Bill substitutedMajor
Apr 15Senate Reset on calendar for 4/16/2026
Apr 15Placed on Senate Regular Calendar for 4/16/2026
Apr 15Sponsor(s) Added.Minor
Apr 13Placed on Senate Regular Calendar for 4/15/2026
Apr 1Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
Vote recorded SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 4/1/2026 Passed. Result: pass.Upper
Mar 25Placed on Senate Health and Welfare Committee calendar for 4/1/2026
Mar 18Reset on Final calendar of Senate Health and Welfare Committee
Mar 17Action deferred in Senate Health and Welfare Committee to 3/18/2026
Mar 17Placed on Senate Health and Welfare Committee calendar for 3/18/2026
Mar 11Placed on Senate Health and Welfare Committee calendar for 3/17/2026
Feb 5Passed on Second Consideration, refer to Senate Health and Welfare CommitteeMinor
Feb 2Filed for introductionMinor
Feb 2Introduced, Passed on First ConsiderationIntroduced